CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) - USD ($)		3 Months Ended		9 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Revenues
Total revenues		$ 0	$ 0	$ 0	$ 0
Operating Expenses
Research and development		245,668	141,976	840,682	555,795
General and administrative		83,116	16,790	281,236	228,106
Total operating expenses		328,784	158,766	1,121,918	783,901
Loss from operations		(328,784)	(158,766)	(1,121,918)	(783,901)
Net Loss		(328,784)	(158,766)	(1,121,918)	(783,901)
Other comprehensive income
Foreign Currency Translation Adjustment		45,662	24,580	27,394	29,434
Comprehensive loss		$ (283,122)	$ (134,186)	$ (1,094,524)	$ (754,467)
Loss per share
Basic and diluted	[1]	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted Average Number of Shares Outstanding		201,902,174	200,000,000	200,636,364	200,000,000

[1] Per share amounts are less than $0.01